Figure 8From: Use of ER/PR/HER2 subtypes in conjunction with the 2007 St Gallen Consensus Statement for early breast cancer Five-year relative survival for node positive cases with >3 lymph nodes within the St Gallen high risk group (high risk 5) according to the ER/PR/HER2 subtypes.Back to article page